GJIA
PRCT icon

Glass Jacobson Investment Advisors’s Procept Biorobotics PRCT Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,300
Closed -$202K – 785
2024
Q2 		$202K Hold
3,300
– – 0.07% 213
2024
Q1 		$163K Hold
3,300
– – 0.06% 230
2023
Q4 		$138K Buy
+3,300
New +$112K 0.06% 240
2023
Q3 		– Sell
-3,300
Closed -$117K – 824
2023
Q2 		$117K Buy
+3,300
New +$109K 0.05% 239

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Glass Jacobson Investment Advisors's PRCT Position: Q3 2024 in Review

Glass Jacobson Investment Advisors sold out of Procept Biorobotics (PRCT) in Q3 2024, closing a stake of 3,300 shares — an estimated $202K sold.

Glass Jacobson Investment Advisors first reported a position in PRCT in Q2 2023 and held it in 4 quarters. The position peaked at $202K in Q2 2024. 250 funds tracked by Wall St. Rank hold PRCT as of Q3 2024.

  • Glass Jacobson Investment Advisors reported no remaining Procept Biorobotics position as of Q3 2024 after selling out during the quarter.
  • Glass Jacobson Investment Advisors sold 3,300 Procept Biorobotics shares in Q3 2024, an estimated $202K.
  • Glass Jacobson Investment Advisors first reported a position in Procept Biorobotics in Q2 2023 and held it in 4 quarters.
  • Glass Jacobson Investment Advisors's Procept Biorobotics position peaked at $202K in Q2 2024.
  • 250 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2024.

Based on Glass Jacobson Investment Advisors's 13F filing for Q3 2024, filed 15 Nov 2024.